0001209191-19-004985.txt : 20190123
0001209191-19-004985.hdr.sgml : 20190123
20190123164813
ACCESSION NUMBER: 0001209191-19-004985
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190121
FILED AS OF DATE: 20190123
DATE AS OF CHANGE: 20190123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kunkel Lori Anne
CENTRAL INDEX KEY: 0001536368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30347
FILM NUMBER: 19537853
MAIL ADDRESS:
STREET 1: C/O PHARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CURIS INC
CENTRAL INDEX KEY: 0001108205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043505116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-503-6500
MAIL ADDRESS:
STREET 1: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-21
0
0001108205
CURIS INC
CRIS
0001536368
Kunkel Lori Anne
4 MAGUIRE ROAD
LEXINGTON
MA
02421
1
0
0
0
Non Qualified Stock Option
1.16
2019-01-21
4
A
0
180000
0.00
A
2029-01-20
Common Stock
180000
180000
D
Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest in twelve equal monthly installments beginning on February 21, 2019 until the award becomes fully vested on January 21, 2020, subject to the director's continued service with the Company.
William Steinkrauss, attorney-in-fact
2019-01-23